Tarek Hegazi

Dr. Tarek Hegazi

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Expert Systems with Applications
Verified
Journal Article
Closed access
MTMahbubunnabi Tamal
Mahbubunnabi Tamal
MAMaha Alshammari
Maha Alshammari
MAMeernah Alabdullah
Meernah Alabdullah
RHRana Hourani
Rana Hourani
HAHossain Abu Alola
Hossain Abu Alola
THTarek Hegazi
Tarek Hegazi

15 August 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
THTarek Hegazi
Tarek Hegazi
Hydroxyapatite deposition disease (HADD) represents a multifaceted condition characterized by the accumulation of hydroxyapatite crystals in soft tissues, leading to subsequent inflammation and discomfort. The intricate etiology of HADD is the subject of this comprehensive review, which encompasses an in-depth analysis of the four proposed pathogenic mechanisms and a deliberation on the predisposing factors that instigate the development of this disease. In order to provide a thorough understanding of the disease’s progression, this manuscript delineates the stages of HADD—those preceding calcification, occurring during calcification, and following calcification—in meticulous detail. This chronology forms the basis of a complete portrayal of the evolution of HADD. Moreover, this review encompasses an examination of the radiological findings associated with HADD, furnishing an extensive discourse on imaging characteristics. The potential of HADD to mimic other diseases, thereby posing diagnostic challenges, is also articulated. The discourse continues with an investigation of HADD’s differential diagnosis. This section furnishes a robust framework for distinguishing HADD from other conditions based on imaging results. To enrich the understanding of this diagnostic process, case studies illustrating real-world applications are provided. An overview of treatment modalities for HADD, including both conservative and interventional approaches, forms the concluding discussion. The pivotal role of imaging specialists in the diagnosis and management of HADD is emphasized, highlighting their vital contribution to image-guided procedures and disease monitoring.

12 November 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
AAAbdullah Yousef Al-Othman
Abdullah Yousef Al-Othman
AAAbdulaziz Al-Sharydah
Abdulaziz Al-Sharydah
EAElfatih Abuelhia
Elfatih Abuelhia
RMRAFAT SAEED MOHTASIB
RAFAT SAEED MOHTASIB
ADABDULMAJEED BIN DAHMASH
ABDULMAJEED BIN DAHMASH
SASalem Alghamdi
Salem Alghamdi
Few studies have reviewed the reduction of doses in Computed tomography (CT), while various diagnostic procedures use ionizing radiation to explore the optimal dose estimate using multiple exposure quantities, including milliampere-seconds, kilovoltage peak, and pitch factors while controlling the CT dose index volume (CTDIvol) and dose length product (DLP). Therefore, we considered optimizing CT protocols to reduce radiation and organ doses during head, chest, abdominal, and pelvic CT examinations. For establishing institutional diagnostic reference levels as a benchmark to correlate with national diagnostic reference levels (NDRLs) in KSA conforming to international guidelines for radiation exposure, 3000 adult-patients underwent imaging of organs. Dose parameters were obtained using Monte Carlo software and adjusted using the Siemens Teamplay™ software. CTDIvol, DLP, and effective dose were 40.67 ± 3.8, 757 ± 63.2, and 1.74 ± 0.19, for head; 14.9 ± 1.38, 547 ± 42.9, and 7.27 ± 0.95 for chest; and 16.84 ± 1.45, 658 ± 53.4, and 10.2 ± 0.66 for abdomen/pelvis, respectively. The NDRL post-optimization comparison showed adequate CT exposure. Head CT parameters required additional optimization to match the NDRL. Therefore, calculations were repeated to assess radiation doses. In conclusion, doses could be substantially minimized by selecting parameters per clinical indication of the study, patient size, and examined body region. Additional dose reduction to superficial organs requires a shielding material.

3 October 2019 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
THTarek Hegazi
Tarek Hegazi
AAAbdulaziz Al-Sharydah
Abdulaziz Al-Sharydah
KLKaren S. Lee
Karen S. Lee
KMKoenraad Mortele
Koenraad Mortele

25 May 2021 in Journal of Ultrasound
Verified
Journal Article
Closed access
PDF file
AAAli M. Alshami
Ali M. Alshami
TATadhi Khulaif Alshammari
Tadhi Khulaif Alshammari
MAMona I. AlMuhaish
Mona I. AlMuhaish
THTarek Hegazi
Tarek Hegazi
MTMahbubunnabi Tamal
Mahbubunnabi Tamal
FAFuad Abdulla
Fuad Abdulla

15 July 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
AAAli B Alhailiy
Ali B Alhailiy
EAEssam Mohammed Alkhaybari
Essam Mohammed Alkhaybari
MAMohammed S Alshuhri
Mohammed S Alshuhri
AAAbdullah Yousef Al-Othman
Abdullah Yousef Al-Othman
THTarek Hegazi
Tarek Hegazi
MMMustafa Z. Mahmoud
Mustafa Z. Mahmoud
Objectives: Diagnostic reference levels (DRLs) are crucial tools for optimizing radiation exposure during different radiological examinations. This study aimed to establish preliminary DRLs for commonly performed computed tomographic angiography (CTA) examinations in Saudi Arabia. Methods: Data for three types of CTA examinations (cerebral, pulmonary, and lower-extremity) were collected from six medical cities across Saudi Arabia. Data sets related to 723 CTAs with a mean patient weight of 75 kg were analysed in detail. The DRL values were determined based on the 75th, median, and 25th CT dose index volume (CTDIvol) and dose length product (DLP) values. Results: The established DRLs were 1221 mGy cm for cerebral CTAs, 475 mGy cm for pulmonary CTAs, and 1040 mGy cm for lower-extremity CTAs. These values were comparable to those reported in other studies. Conclusions: This study provides preliminary DRLs for three common CTA procedures in Saudi Arabia. The widespread implementation of a low kVp and a high level of image reconstruction (IR) presents an opportunity for further dose reduction. These findings can serve as a foundation for future nationwide DRL surveys and the optimization of CTA imaging protocols in Saudi Arabia.